EFFICACY AND SAFETY OF SEQUENTIAL DIFFERENT B CELL ANTIGEN-TARGETED CAR T-CELL THERAPY FOR PEDIATRIC REFRACTORY/RELAPSED BURKITT LYMPHOMAWITH SECONDARY CENTRAL NERVOUS SYSTEM INVOLVEMENT

被引：0
|
作者：
Liu, Y. [1 ]
Deng, B. [2 ]
Hu, B. [1 ]
Zhang, W. [1 ]
Zhu, Q. [1 ]
Liu, Y. [1 ]
Wang, S. [1 ]
Zhang, P. [1 ]
Yang, J. [1 ]
Zheng, Q. [3 ]
Yu, X. [3 ]
Gao, Z. [4 ]
Zhou, C. [5 ]
Han, W. [6 ]
Chang, A. [7 ]
Zhang, Y. [1 ]
机构：
[1] Beijing Boren Hosp, Dept Pediat Lymphoma, Beijing, Peoples R China
[2] Beijing Boren Hosp, Cytol Lab, Beijing, Peoples R China
[3] Beijing Boren Hosp, Med Lab, Beijing, Peoples R China
[4] Peking Univ Third Hosp, Dept Pathol, Beijing, Peoples R China
[5] Capital Med Univ, Beijing Childrens Hosp, Dept Pathol, Natl Ctr Childrens Hlth, Beijing, Peoples R China
[6] Chinese Acad Med Sci & Peking Union Med Coll, Dept Epidemiol & Biostat, Inst Basic Med Sci, Sch Basic Med, Beijing, Peoples R China
[7] Tongji Univ, Sch Med, Clin Translat Res Ctr, Shanghai Pulm Hosp, Shanghai, Peoples R China
来源：
LEUKEMIA RESEARCH | 2022年 / 121卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
046
引用
收藏
页码：S32 / S33
页数：2
相关论文
共 50 条
  • [1] Efficacy and Safety of Sequential Different B Cell AntigenTargeted CAR T-Cell Therapy for Pediatric Refractory/Relapsed Burkitt Lymphoma with Secondary Central Nervous System Involvement
    Liu, Ying
    Deng, Biping
    Hu, Bo
    Zhang, Wenqun
    Zhu, Qing
    Liu, Yang
    Wang, Shan
    Zhang, Pei
    Yang, Junhan
    Zheng, Qinglong
    Yu, Xinjian
    Gao, Zifen
    Zhou, Chunju
    Han, Wei
    Chang, Alex Hong
    Zhang, Yonghong
    BLOOD, 2021, 138
  • [2] Sequential different B-cell antigen-targeted CAR T-cell therapy for pediatric refractory/relapsed Burkitt lymphoma
    Liu, Ying
    Deng, Biping
    Hu, Bo
    Zhang, Wenqun
    Zhu, Qing
    Liu, Yang
    Wang, Shan
    Zhang, Pei
    Yang, Ying
    Yang, Junhan
    Zheng, Qinlong
    Yu, Xinjian
    Gao, Zifen
    Zhou, Chunju
    Han, Wei
    Yang, Jing
    Jin, Ling
    Tong, Chunrong
    Chang, Alex H.
    Zhang, Yonghong
    BLOOD ADVANCES, 2022, 6 (03) : 717 - 730
  • [3] Clinical efficacy and safety of chimeric antigen receptor T-cell therapy for mantle cell lymphoma with secondary central nervous system involvement
    Ryan, Christine E.
    Zon, Rebecca L.
    Redd, Robert
    Fisher, David C.
    Shouval, Roni
    Kumar, Anita
    Crombie, Jennifer L.
    Sadrzadeh, Hossein
    Kim, Austin I.
    Nayak, Lakshmi
    Chukwueke, Ugonma N.
    Jacobson, Caron A.
    Frigault, Matthew J.
    Palomba, M. Lia
    Armand, Philippe
    Epstein-Peterson, Zachary
    Merryman, Reid W.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 203 (05) : 774 - 780
  • [4] Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement
    Lionel, Anath C.
    Gurumurthi, Ashwath
    Fetooh, Ahmed
    Eldaya, Rami
    Ahmed, Sairah
    Iyer, Swaminathan P.
    Nastoupil, Loretta J.
    Westin, Jason
    Nair, Ranjit
    Fayad, Luis
    Malpica, Luis
    Tummala, Sudhakar
    Flowers, Christopher
    Neelapu, Sattva S.
    Wang, Michael L.
    Jain, Preetesh
    LEUKEMIA & LYMPHOMA, 2024, 65 (05) : 669 - 673
  • [5] Sequential CAR T-Cell Therapy After Autologous Stem Cell Transplantation for the Treatment of Relapsed/Refractory Intravascular Large B-Cell Lymphoma With Central Nervous System Involvement: A Case Report
    Liu, Wanying
    Li, Chunrui
    Cao, Yang
    Wang, Na
    Huang, Liang
    Shang, Zhen
    Wang, Jue
    Huang, Lifang
    Xu, Jinhuan
    Xiao, Min
    Zhang, Yicheng
    Zhou, Jianfeng
    Chen, Liting
    Xiao, Yi
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] FEASIBILITY, SAFETY, AND EFFICACY OF RADIATION THERAPY AS A BRIDGING STRATEGY FOR CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY FOR RELAPSED/REFRACTORY AGGRESSIVE B-CELL LYMPHOMA
    Laprade, Selena
    Babadagli, Ege
    Islam, Nabil
    Samant, Rajiv
    Kennah, Michael
    Kekre, Natasha
    Maltez, Melissa
    Tan, Sherry
    Nair, Vimoj
    RADIOTHERAPY AND ONCOLOGY, 2024, 198 : S48 - S48
  • [7] Chimeric Antigen Receptor T-Cell (CAR T-Cell) Therapy for Primary and Secondary Central Nervous System Lymphoma: A Systematic Review of Literature
    Asghar, Noureen
    Masood, Adeel
    Dhaliwal, Armaan
    Khurana, Sharad
    Davis, James
    Hashmi, Hamza
    Husnain, Muhammad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (01): : 15 - 21
  • [8] Safety and Efficacy of Chimeric Antigen Receptor T-Cell Therapy in Children With Central Nervous System Leukemia
    Zhang, Lin
    Zuo, Yingxi
    Lu, Aidong
    Wu, Jun
    Jia, Yueping
    Wang, Yu
    Zhang, Leping
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (04): : E410 - E414
  • [9] Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies
    Wang, Na
    Hu, Xuelian
    Cao, Wenyue
    Li, Chunrui
    Xiao, Yi
    Cao, Yang
    Gu, Chaojiang
    Zhang, Shangkun
    Chen, Liting
    Cheng, Jiali
    Wang, Gaoxiang
    Zhou, Xiaoxi
    Zheng, Miao
    Mao, Xia
    Jiang, Lijun
    Wang, Di
    Wang, Qiuxiang
    Lou, Yaoyao
    Cai, Haodong
    Yan, Dandan
    Zhang, Yicheng
    Zhang, Tongcun
    Zhou, Jianfeng
    Huang, Liang
    BLOOD, 2020, 135 (01) : 17 - 27
  • [10] CAR T-cell Therapy for Central Nervous System Lymphoma
    Houillier, Caroline
    Choquet, Sylvain
    CURRENT ONCOLOGY REPORTS, 2024, 26 (11) : 1521 - 1529
12345